ReviewCells2022

Advances in Allogeneic Cancer Cell Therapy and Future Perspectives on "Off-the-Shelf" T Cell Therapy Using iPSC Technology and Gene Editing.

Yoshiki Furukawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.